Chimeric antigen receptor (CAR) T-cell therapy is a way to get immune cells called T cells (a type of white blood cell) to fight cancer by changing them in the lab so they can find and destroy cancer cells. CAR T-cell therapy is also sometimes talked about as a type of cell-based gene therapy, because it involves altering the genes inside T cells to help them attack the cancer.
This report aims to provide a comprehensive presentation of the global market for CAR T-Cell Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CAR T-Cell Therapy. This report contains market size and forecasts of CAR T-Cell Therapy in global, including the following market information:
Global CAR T-Cell Therapy Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global CAR T-Cell Therapy market was valued at US$ 1770.5 million in 2022 and is projected to reach US$ 10330 million by 2029, at a CAGR of 28.7% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The global top three CAR T-Cell therapy players include Novartis, Gilead Sciences, Bristol-Myers Squibb, with a total market share of more than 99%. The largest player is Gilead Sciences, with a market share of over 50%. North America is the global most important consumer market for CAR T-Cell therapy, with a market share of more than 65%. In terms of type, CD19-targeted CAR cell therapy has a market share of over 90%. In the field of application, the market share of lymphoma exceeds 90%.
We surveyed the CAR T-Cell Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global CAR T-Cell Therapy Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global CAR T-Cell Therapy Market Segment Percentages, by Type, 2022 (%)
CD19 - Targeted
BCMA - Targeted
Global CAR T-Cell Therapy Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global CAR T-Cell Therapy Market Segment Percentages, by Application, 2022 (%)
Lymphoma
Multiple Myeloma
Global CAR T-Cell Therapy Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global CAR T-Cell Therapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies CAR T-Cell Therapy revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies CAR T-Cell Therapy revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis
Gilead Sciences
Bristol-Myers Squibb
J & J
JW Therapeutics
FOSUNKite
CARsgen Therapeutics (Pipeline)
Autolus Therapeutics(Pipeline)
Sorrento Therapeutics(Pipeline)
Mustang Bio(Pipeline)
Bluebird Bio(Pipeline)
Cellectis(Pipeline)
Allogene Therapeutics(Pipeline)
Celyad(Pipeline)
Outline of Major Chapters:
Chapter 1: Introduces the definition of CAR T-Cell Therapy, market overview.
Chapter 2: Global CAR T-Cell Therapy market size in revenue.
Chapter 3: Detailed analysis of CAR T-Cell Therapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of CAR T-Cell Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 CAR T-Cell Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global CAR T-Cell Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global CAR T-Cell Therapy Overall Market Size
2.1 Global CAR T-Cell Therapy Market Size: 2022 VS 2029
2.2 Global CAR T-Cell Therapy Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top CAR T-Cell Therapy Players in Global Market
3.2 Top Global CAR T-Cell Therapy Companies Ranked by Revenue
3.3 Global CAR T-Cell Therapy Revenue by Companies
3.4 Top 3 and Top 5 CAR T-Cell Therapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies CAR T-Cell Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 CAR T-Cell Therapy Players in Global Market
3.6.1 List of Global Tier 1 CAR T-Cell Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 CAR T-Cell Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global CAR T-Cell Therapy Market Size Markets, 2022 & 2029
4.1.2 CD19 - Targeted
4.1.3 BCMA - Targeted
4.2 By Type - Global CAR T-Cell Therapy Revenue & Forecasts
4.2.1 By Type - Global CAR T-Cell Therapy Revenue, 2018-2023
4.2.2 By Type - Global CAR T-Cell Therapy Revenue, 2024-2029
4.2.3 By Type - Global CAR T-Cell Therapy Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global CAR T-Cell Therapy Market Size, 2022 & 2029
5.1.2 Lymphoma
5.1.3 Multiple Myeloma
5.2 By Application - Global CAR T-Cell Therapy Revenue & Forecasts
5.2.1 By Application - Global CAR T-Cell Therapy Revenue, 2018-2023
5.2.2 By Application - Global CAR T-Cell Therapy Revenue, 2024-2029
5.2.3 By Application - Global CAR T-Cell Therapy Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global CAR T-Cell Therapy Market Size, 2022 & 2029
6.2 By Region - Global CAR T-Cell Therapy Revenue & Forecasts
6.2.1 By Region - Global CAR T-Cell Therapy Revenue, 2018-2023
6.2.2 By Region - Global CAR T-Cell Therapy Revenue, 2024-2029
6.2.3 By Region - Global CAR T-Cell Therapy Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America CAR T-Cell Therapy Revenue, 2018-2029
6.3.2 US CAR T-Cell Therapy Market Size, 2018-2029
6.3.3 Canada CAR T-Cell Therapy Market Size, 2018-2029
6.3.4 Mexico CAR T-Cell Therapy Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe CAR T-Cell Therapy Revenue, 2018-2029
6.4.2 Germany CAR T-Cell Therapy Market Size, 2018-2029
6.4.3 France CAR T-Cell Therapy Market Size, 2018-2029
6.4.4 U.K. CAR T-Cell Therapy Market Size, 2018-2029
6.4.5 Italy CAR T-Cell Therapy Market Size, 2018-2029
6.4.6 Russia CAR T-Cell Therapy Market Size, 2018-2029
6.4.7 Nordic Countries CAR T-Cell Therapy Market Size, 2018-2029
6.4.8 Benelux CAR T-Cell Therapy Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia CAR T-Cell Therapy Revenue, 2018-2029
6.5.2 China CAR T-Cell Therapy Market Size, 2018-2029
6.5.3 Japan CAR T-Cell Therapy Market Size, 2018-2029
6.5.4 South Korea CAR T-Cell Therapy Market Size, 2018-2029
6.5.5 Southeast Asia CAR T-Cell Therapy Market Size, 2018-2029
6.5.6 India CAR T-Cell Therapy Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America CAR T-Cell Therapy Revenue, 2018-2029
6.6.2 Brazil CAR T-Cell Therapy Market Size, 2018-2029
6.6.3 Argentina CAR T-Cell Therapy Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa CAR T-Cell Therapy Revenue, 2018-2029
6.7.2 Turkey CAR T-Cell Therapy Market Size, 2018-2029
6.7.3 Israel CAR T-Cell Therapy Market Size, 2018-2029
6.7.4 Saudi Arabia CAR T-Cell Therapy Market Size, 2018-2029
6.7.5 UAE CAR T-Cell Therapy Market Size, 2018-2029
7 CAR T-Cell Therapy Companies Profiles
7.1 Novartis
7.1.1 Novartis Company Summary
7.1.2 Novartis Business Overview
7.1.3 Novartis CAR T-Cell Therapy Major Product Offerings
7.1.4 Novartis CAR T-Cell Therapy Revenue in Global Market (2018-2023)
7.1.5 Novartis Key News & Latest Developments
7.2 Gilead Sciences
7.2.1 Gilead Sciences Company Summary
7.2.2 Gilead Sciences Business Overview
7.2.3 Gilead Sciences CAR T-Cell Therapy Major Product Offerings
7.2.4 Gilead Sciences CAR T-Cell Therapy Revenue in Global Market (2018-2023)
7.2.5 Gilead Sciences Key News & Latest Developments
7.3 Bristol-Myers Squibb
7.3.1 Bristol-Myers Squibb Company Summary
7.3.2 Bristol-Myers Squibb Business Overview
7.3.3 Bristol-Myers Squibb CAR T-Cell Therapy Major Product Offerings
7.3.4 Bristol-Myers Squibb CAR T-Cell Therapy Revenue in Global Market (2018-2023)
7.3.5 Bristol-Myers Squibb Key News & Latest Developments
7.4 J & J
7.4.1 J & J Company Summary
7.4.2 J & J Business Overview
7.4.3 J & J CAR T-Cell Therapy Major Product Offerings
7.4.4 J & J CAR T-Cell Therapy Revenue in Global Market (2018-2023)
7.4.5 J & J Key News & Latest Developments
7.5 JW Therapeutics
7.5.1 JW Therapeutics Company Summary
7.5.2 JW Therapeutics Business Overview
7.5.3 JW Therapeutics CAR T-Cell Therapy Major Product Offerings
7.5.4 JW Therapeutics CAR T-Cell Therapy Revenue in Global Market (2018-2023)
7.5.5 JW Therapeutics Key News & Latest Developments
7.6 FOSUNKite
7.6.1 FOSUNKite Company Summary
7.6.2 FOSUNKite Business Overview
7.6.3 FOSUNKite CAR T-Cell Therapy Major Product Offerings
7.6.4 FOSUNKite CAR T-Cell Therapy Revenue in Global Market (2018-2023)
7.6.5 FOSUNKite Key News & Latest Developments
7.7 CARsgen Therapeutics (Pipeline)
7.7.1 CARsgen Therapeutics (Pipeline) Company Summary
7.7.2 CARsgen Therapeutics (Pipeline) Business Overview
7.7.3 CARsgen Therapeutics (Pipeline) CAR T-Cell Therapy Major Product Offerings
7.7.4 CARsgen Therapeutics (Pipeline) CAR T-Cell Therapy Revenue in Global Market (2018-2023)
7.7.5 CARsgen Therapeutics (Pipeline) Key News & Latest Developments
7.8 Autolus Therapeutics(Pipeline)
7.8.1 Autolus Therapeutics(Pipeline) Company Summary
7.8.2 Autolus Therapeutics(Pipeline) Business Overview
7.8.3 Autolus Therapeutics(Pipeline) CAR T-Cell Therapy Major Product Offerings
7.8.4 Autolus Therapeutics(Pipeline) CAR T-Cell Therapy Revenue in Global Market (2018-2023)
7.8.5 Autolus Therapeutics(Pipeline) Key News & Latest Developments
7.9 Sorrento Therapeutics(Pipeline)
7.9.1 Sorrento Therapeutics(Pipeline) Company Summary
7.9.2 Sorrento Therapeutics(Pipeline) Business Overview
7.9.3 Sorrento Therapeutics(Pipeline) CAR T-Cell Therapy Major Product Offerings
7.9.4 Sorrento Therapeutics(Pipeline) CAR T-Cell Therapy Revenue in Global Market (2018-2023)
7.9.5 Sorrento Therapeutics(Pipeline) Key News & Latest Developments
7.10 Mustang Bio(Pipeline)
7.10.1 Mustang Bio(Pipeline) Company Summary
7.10.2 Mustang Bio(Pipeline) Business Overview
7.10.3 Mustang Bio(Pipeline) CAR T-Cell Therapy Major Product Offerings
7.10.4 Mustang Bio(Pipeline) CAR T-Cell Therapy Revenue in Global Market (2018-2023)
7.10.5 Mustang Bio(Pipeline) Key News & Latest Developments
7.11 Bluebird Bio(Pipeline)
7.11.1 Bluebird Bio(Pipeline) Company Summary
7.11.2 Bluebird Bio(Pipeline) Business Overview
7.11.3 Bluebird Bio(Pipeline) CAR T-Cell Therapy Major Product Offerings
7.11.4 Bluebird Bio(Pipeline) CAR T-Cell Therapy Revenue in Global Market (2018-2023)
7.11.5 Bluebird Bio(Pipeline) Key News & Latest Developments
7.12 Cellectis(Pipeline)
7.12.1 Cellectis(Pipeline) Company Summary
7.12.2 Cellectis(Pipeline) Business Overview
7.12.3 Cellectis(Pipeline) CAR T-Cell Therapy Major Product Offerings
7.12.4 Cellectis(Pipeline) CAR T-Cell Therapy Revenue in Global Market (2018-2023)
7.12.5 Cellectis(Pipeline) Key News & Latest Developments
7.13 Allogene Therapeutics(Pipeline)
7.13.1 Allogene Therapeutics(Pipeline) Company Summary
7.13.2 Allogene Therapeutics(Pipeline) Business Overview
7.13.3 Allogene Therapeutics(Pipeline) CAR T-Cell Therapy Major Product Offerings
7.13.4 Allogene Therapeutics(Pipeline) CAR T-Cell Therapy Revenue in Global Market (2018-2023)
7.13.5 Allogene Therapeutics(Pipeline) Key News & Latest Developments
7.14 Celyad(Pipeline)
7.14.1 Celyad(Pipeline) Company Summary
7.14.2 Celyad(Pipeline) Business Overview
7.14.3 Celyad(Pipeline) CAR T-Cell Therapy Major Product Offerings
7.14.4 Celyad(Pipeline) CAR T-Cell Therapy Revenue in Global Market (2018-2023)
7.14.5 Celyad(Pipeline) Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. CAR T-Cell Therapy Market Opportunities & Trends in Global Market
Table 2. CAR T-Cell Therapy Market Drivers in Global Market
Table 3. CAR T-Cell Therapy Market Restraints in Global Market
Table 4. Key Players of CAR T-Cell Therapy in Global Market
Table 5. Top CAR T-Cell Therapy Players in Global Market, Ranking by Revenue (2022)
Table 6. Global CAR T-Cell Therapy Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global CAR T-Cell Therapy Revenue Share by Companies, 2018-2023
Table 8. Global Companies CAR T-Cell Therapy Product Type
Table 9. List of Global Tier 1 CAR T-Cell Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 CAR T-Cell Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global CAR T-Cell Therapy Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - CAR T-Cell Therapy Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - CAR T-Cell Therapy Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global CAR T-Cell Therapy Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - CAR T-Cell Therapy Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - CAR T-Cell Therapy Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global CAR T-Cell Therapy Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global CAR T-Cell Therapy Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global CAR T-Cell Therapy Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America CAR T-Cell Therapy Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America CAR T-Cell Therapy Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe CAR T-Cell Therapy Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe CAR T-Cell Therapy Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia CAR T-Cell Therapy Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia CAR T-Cell Therapy Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America CAR T-Cell Therapy Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America CAR T-Cell Therapy Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa CAR T-Cell Therapy Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa CAR T-Cell Therapy Revenue, (US$, Mn), 2024-2029
Table 30. Novartis Company Summary
Table 31. Novartis CAR T-Cell Therapy Product Offerings
Table 32. Novartis CAR T-Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 33. Novartis Key News & Latest Developments
Table 34. Gilead Sciences Company Summary
Table 35. Gilead Sciences CAR T-Cell Therapy Product Offerings
Table 36. Gilead Sciences CAR T-Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 37. Gilead Sciences Key News & Latest Developments
Table 38. Bristol-Myers Squibb Company Summary
Table 39. Bristol-Myers Squibb CAR T-Cell Therapy Product Offerings
Table 40. Bristol-Myers Squibb CAR T-Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 41. Bristol-Myers Squibb Key News & Latest Developments
Table 42. J & J Company Summary
Table 43. J & J CAR T-Cell Therapy Product Offerings
Table 44. J & J CAR T-Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 45. J & J Key News & Latest Developments
Table 46. JW Therapeutics Company Summary
Table 47. JW Therapeutics CAR T-Cell Therapy Product Offerings
Table 48. JW Therapeutics CAR T-Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 49. JW Therapeutics Key News & Latest Developments
Table 50. FOSUNKite Company Summary
Table 51. FOSUNKite CAR T-Cell Therapy Product Offerings
Table 52. FOSUNKite CAR T-Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 53. FOSUNKite Key News & Latest Developments
Table 54. CARsgen Therapeutics (Pipeline) Company Summary
Table 55. CARsgen Therapeutics (Pipeline) CAR T-Cell Therapy Product Offerings
Table 56. CARsgen Therapeutics (Pipeline) CAR T-Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 57. CARsgen Therapeutics (Pipeline) Key News & Latest Developments
Table 58. Autolus Therapeutics(Pipeline) Company Summary
Table 59. Autolus Therapeutics(Pipeline) CAR T-Cell Therapy Product Offerings
Table 60. Autolus Therapeutics(Pipeline) CAR T-Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 61. Autolus Therapeutics(Pipeline) Key News & Latest Developments
Table 62. Sorrento Therapeutics(Pipeline) Company Summary
Table 63. Sorrento Therapeutics(Pipeline) CAR T-Cell Therapy Product Offerings
Table 64. Sorrento Therapeutics(Pipeline) CAR T-Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 65. Sorrento Therapeutics(Pipeline) Key News & Latest Developments
Table 66. Mustang Bio(Pipeline) Company Summary
Table 67. Mustang Bio(Pipeline) CAR T-Cell Therapy Product Offerings
Table 68. Mustang Bio(Pipeline) CAR T-Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 69. Mustang Bio(Pipeline) Key News & Latest Developments
Table 70. Bluebird Bio(Pipeline) Company Summary
Table 71. Bluebird Bio(Pipeline) CAR T-Cell Therapy Product Offerings
Table 72. Bluebird Bio(Pipeline) CAR T-Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 73. Bluebird Bio(Pipeline) Key News & Latest Developments
Table 74. Cellectis(Pipeline) Company Summary
Table 75. Cellectis(Pipeline) CAR T-Cell Therapy Product Offerings
Table 76. Cellectis(Pipeline) CAR T-Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 77. Cellectis(Pipeline) Key News & Latest Developments
Table 78. Allogene Therapeutics(Pipeline) Company Summary
Table 79. Allogene Therapeutics(Pipeline) CAR T-Cell Therapy Product Offerings
Table 80. Allogene Therapeutics(Pipeline) CAR T-Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 81. Allogene Therapeutics(Pipeline) Key News & Latest Developments
Table 82. Celyad(Pipeline) Company Summary
Table 83. Celyad(Pipeline) CAR T-Cell Therapy Product Offerings
Table 84. Celyad(Pipeline) CAR T-Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 85. Celyad(Pipeline) Key News & Latest Developments
List of Figures
Figure 1. CAR T-Cell Therapy Segment by Type in 2022
Figure 2. CAR T-Cell Therapy Segment by Application in 2022
Figure 3. Global CAR T-Cell Therapy Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global CAR T-Cell Therapy Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global CAR T-Cell Therapy Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by CAR T-Cell Therapy Revenue in 2022
Figure 8. By Type - Global CAR T-Cell Therapy Revenue Market Share, 2018-2029
Figure 9. By Application - Global CAR T-Cell Therapy Revenue Market Share, 2018-2029
Figure 10. By Type - Global CAR T-Cell Therapy Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global CAR T-Cell Therapy Revenue Market Share, 2018-2029
Figure 12. By Application - Global CAR T-Cell Therapy Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global CAR T-Cell Therapy Revenue Market Share, 2018-2029
Figure 14. By Region - Global CAR T-Cell Therapy Revenue Market Share, 2018-2029
Figure 15. By Country - North America CAR T-Cell Therapy Revenue Market Share, 2018-2029
Figure 16. US CAR T-Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 17. Canada CAR T-Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico CAR T-Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe CAR T-Cell Therapy Revenue Market Share, 2018-2029
Figure 20. Germany CAR T-Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 21. France CAR T-Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. CAR T-Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 23. Italy CAR T-Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 24. Russia CAR T-Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries CAR T-Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux CAR T-Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia CAR T-Cell Therapy Revenue Market Share, 2018-2029
Figure 28. China CAR T-Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 29. Japan CAR T-Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea CAR T-Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia CAR T-Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 32. India CAR T-Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America CAR T-Cell Therapy Revenue Market Share, 2018-2029
Figure 34. Brazil CAR T-Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina CAR T-Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa CAR T-Cell Therapy Revenue Market Share, 2018-2029
Figure 37. Turkey CAR T-Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 38. Israel CAR T-Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia CAR T-Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 40. UAE CAR T-Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 41. Novartis CAR T-Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Gilead Sciences CAR T-Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Bristol-Myers Squibb CAR T-Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. J & J CAR T-Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. JW Therapeutics CAR T-Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. FOSUNKite CAR T-Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. CARsgen Therapeutics (Pipeline) CAR T-Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Autolus Therapeutics(Pipeline) CAR T-Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Sorrento Therapeutics(Pipeline) CAR T-Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Mustang Bio(Pipeline) CAR T-Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Bluebird Bio(Pipeline) CAR T-Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Cellectis(Pipeline) CAR T-Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Allogene Therapeutics(Pipeline) CAR T-Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Celyad(Pipeline) CAR T-Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
